Zynex Inc (ZYXI) Inventory Turnover Ratio, from third quarter 2025 to third quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Zynex inc   (NASDAQ: ZYXI)
 

Zynex Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Zynex Inc 's inventory turnover ratio, the ratio that measures Zynex Inc 's ability to manage its supply chain, sequentially decreased to 2.38 in the third quarter 2025, which does not come as a surprise, as the Zynex Inc continue to experience headwinds, which also impact its supply chain. Zynex Inc 's average inventory processing period in the Sep 30 2025 quarter, has increased to 153 days, from 142 days, in the Jun 30 2025 quarter.

Within Healthcare sector 171 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 788 in the second quarter 2025, to 1179.

ZYXI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zynex Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZYXI Inventory Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Inventory Growth -23.66 % -20.66 % -12.57 % 6.2 % 10.73 %
Y / Y Cost of Sales Growth -48.11 % -29.24 % -9.99 % -2.81 % 6.53 %
Inventory Turnover Ratio (TTM) 2.38 2.57 2.63 2.61 2.66
ZYXI's Total Ranking # 1179 # 788 # 787 # 924 #
Average inventory processing period 154 142 139 140 137
Seq. Inventory Growth -1.8 % -9.76 % -2.79 % -11.39 % 2.07 %
Seq. Cost of Sales Growth -25.15 % -15.7 % -16.17 % -1.91 % 2.07 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 172
Overall Market # 1179

Inventory Turnover Ratio Statistics
High Average Low
93.87 10.42 1.38
(Dec 31 2016)   (Sep 30 2012)



ZYXI Company Profile >> Back to ZYXI Efficiency Comparisons >> Compare ZYXI Inventory Turnover Ratio to its Competitors

Financial Statements
Zynex Inc 's Inventories $ 12 Millions Visit ZYXI's Balance sheet
Zynex Inc 's Cost of Revenues TTM $ 31 Millions Visit ZYXI's Income Statement
What are ZYXI's Sales? Visit ZYXI's Sales by Segment

Other Inventory Turnover Ratios
Zynex Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZYXI's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZYXI's Competitors
Inventory Turnover Ratio for ZYXI's Suppliers
Inventory Turnover Ratio for ZYXI's Customers

You may also want to know
ZYXI's Sales Growth Rates ZYXI's Pe Price to earnings ratio ZYXI's Receivables Turnover Ratio ZYXI's Stock Quote
ZYXI's Net Income Growth Rates ZYXI's Ps Price to Sales ratio ZYXI's Sales per Employee ZYXI's Asset Turnover Ratio
ZYXI's Net Margin ZYXI's Pb Price to Book ratio ZYXI's Financial Strength Ratios ZYXI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Alnylam Pharmaceuticals Inc   7.04 $ 512.092  Millions$ 73  Millions
Fonar Corporation  6.98 $ 19.414  Millions$ 3  Millions
Neuraxis Inc   6.94 $ 0.561  Millions$ 0  Millions
Lucid Diagnostics Inc   6.86 $ 3.114  Millions$ 0  Millions
Kewaunee Scientific Corporation  6.55 $ 203.000  Millions$ 31  Millions
Carlisle Companies Incorporated  6.44 $ 3,197.600  Millions$ 496  Millions
Scorpius Holdings inc   6.44 $ 1.303  Millions$ 0  Millions
Charles River Laboratories International inc   6.12 $ 1,761.939  Millions$ 288  Millions
Vanda Pharmaceuticals Inc   6.01 $ 11.801  Millions$ 2  Millions
Adm Tronics Unlimited Inc   5.82 $ 2.047  Millions$ 0  Millions
Bionexus Gene Lab Corp   5.82 $ 6.967  Millions$ 1  Millions
Avantor Inc   5.75 $ 4,396.800  Millions$ 764  Millions
Hims and Hers Health Inc   5.68 $ 551.000  Millions$ 97  Millions
Moderna Inc   5.65 $ 1,155.000  Millions$ 204  Millions
Scilex Holding Company  5.60 $ 12.676  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   5.60 $ 18.767  Millions$ 3  Millions
Exact Sciences Corporation  5.57 $ 940.831  Millions$ 169  Millions
Harrow Inc   5.55 $ 63.601  Millions$ 11  Millions
Puma Biotechnology Inc   5.51 $ 48.951  Millions$ 9  Millions
Veracyte Inc   5.47 $ 125.021  Millions$ 23  Millions
Bristol myers Squibb Company  5.47 $ 14,652.000  Millions$ 2,680  Millions
Transmedics Group Inc   5.19 $ 224.949  Millions$ 43  Millions
Align Technology inc   5.17 $ 1,258.000  Millions$ 243  Millions
Cannapharmarx Inc   5.15 $ 4.960  Millions$ 1  Millions
Integer Holdings Corporation  5.12 $ 1,328.000  Millions$ 259  Millions
Zai Lab Limited  5.05 $ 170.001  Millions$ 34  Millions
Nuo Therapeutics Inc   5.01 $ 0.774  Millions$ 0  Millions
Steris Plc  4.97 $ 3,177.058  Millions$ 639  Millions
Precision Optics Corporation Inc   4.90 $ 18.342  Millions$ 4  Millions
Ufp Technologies Inc   4.89 $ 426.000  Millions$ 87  Millions

Date modified: 2026-09-08T15:11:35+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.